BioNTech, UPenn Near Settling Covid-Shot Royalties Patent Suit

BioNTech SE and the University of Pennsylvania asked a federal court to pause a lawsuit seeking a greater share of $75 billion in Comirnaty’s global sales for patented mRNA technology crucial for the Covid-19 vaccine so they can finish settlement negotiations.

The parties “are diligently working to reach agreement on the precise terms of the settlement” and believe that staying all proceedings until Dec. 30 will allow them to complete the negotiations and “determine whether they are able to resolve amicably this lawsuit,” according to a joint stipulation and proposed order filed Monday in the US District Court for the ...